Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: Q4Q789
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0020037 | heme binding | 4 | 2 |
GO:0046906 | tetrapyrrole binding | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140575 | transmembrane monodehydroascorbate reductase activity | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.295 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.462 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.354 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.370 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.295 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.364 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.370 |
CLV_PCSK_PC7_1 | 81 | 87 | PF00082 | 0.321 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.259 |
DOC_MAPK_gen_1 | 29 | 36 | PF00069 | 0.560 |
DOC_MAPK_MEF2A_6 | 176 | 184 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 29 | 38 | PF00069 | 0.549 |
DOC_PP1_SILK_1 | 154 | 159 | PF00149 | 0.390 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.633 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.553 |
LIG_Actin_WH2_2 | 144 | 160 | PF00022 | 0.390 |
LIG_Actin_WH2_2 | 67 | 83 | PF00022 | 0.477 |
LIG_EH1_1 | 57 | 65 | PF00400 | 0.368 |
LIG_FHA_1 | 179 | 185 | PF00498 | 0.406 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.493 |
LIG_FHA_2 | 2 | 8 | PF00498 | 0.746 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.317 |
LIG_LIR_Gen_1 | 121 | 130 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 48 | 59 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 121 | 125 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.328 |
LIG_LYPXL_yS_3 | 129 | 132 | PF13949 | 0.321 |
LIG_SH2_CRK | 122 | 126 | PF00017 | 0.385 |
LIG_SH2_CRK | 57 | 61 | PF00017 | 0.282 |
LIG_SH2_NCK_1 | 51 | 55 | PF00017 | 0.343 |
LIG_SH2_STAP1 | 199 | 203 | PF00017 | 0.404 |
LIG_SH2_STAP1 | 51 | 55 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.563 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.433 |
LIG_SH3_2 | 163 | 168 | PF14604 | 0.584 |
LIG_SH3_3 | 157 | 163 | PF00018 | 0.574 |
LIG_SUMO_SIM_par_1 | 179 | 185 | PF11976 | 0.355 |
LIG_TRFH_1 | 159 | 163 | PF08558 | 0.447 |
LIG_TYR_ITIM | 120 | 125 | PF00017 | 0.477 |
LIG_WRC_WIRS_1 | 104 | 109 | PF05994 | 0.477 |
MOD_CDC14_SPxK_1 | 87 | 90 | PF00782 | 0.346 |
MOD_CDK_SPxK_1 | 84 | 90 | PF00069 | 0.346 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.573 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.390 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.539 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.391 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.473 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.330 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.498 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.672 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.393 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.501 |
MOD_PK_1 | 176 | 182 | PF00069 | 0.480 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.509 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.709 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.390 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.456 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.150 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.597 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.409 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.434 |
MOD_SUMO_rev_2 | 72 | 80 | PF00179 | 0.390 |
TRG_DiLeu_BaLyEn_6 | 165 | 170 | PF01217 | 0.356 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 129 | 132 | PF00928 | 0.477 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.317 |
TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.354 |
TRG_Pf-PMV_PEXEL_1 | 75 | 79 | PF00026 | 0.259 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNM4 | Bodo saltans | 26% | 95% |
A0A1X0P2F3 | Trypanosomatidae | 27% | 92% |
A0A3Q8IC17 | Leishmania donovani | 89% | 100% |
A0A3R7RSY6 | Trypanosoma rangeli | 29% | 94% |
A4HID6 | Leishmania braziliensis | 68% | 97% |
A4I5N2 | Leishmania infantum | 84% | 100% |
C9ZR03 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 95% |
E9B0X7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5BPF8 | Trypanosoma cruzi | 26% | 95% |